Home > Healthcare > Biotechnology > Biopharma > Stem Cell Therapy Market

Stem Cell Therapy Market Share

Name: Stem Cell Therapy Market - Size & Share Report, 2032
Creator: Global Market Insights
License: https://www.gminsights.com/privacy-policy

Report ID: GMI3331
Published Date: Feb 2023
Report Format: PDF

Download Free Sample

Stem Cell Therapy Market Share

The leading stem cell therapy market players include

FUJIFILM Cellular Dynamics, Inc.
Novadip Biosciences
DiscGenics
Mesoblast Ltd.
GSK plc.
ThermoGenesis Holdings, Inc.
MEDIPOST Co., Ltd.

Many of these players are focusing on capacity expansion initiatives to increase their market footprint. For instance, in May 2022, Japanese multinational pharmaceutical company, Takeda Pharmaceutical Company Limited, inaugurated Ireland’s first stem cell center in Grange Castle. The facility will aid the distribution of cell therapy treatment options to patients in US, EU, and Canada.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global stem cell therapy market held a valuation of over USD 11.8 billion in 2022, with Global Market Insights, Inc., projections expecting it to grow at over 10% CAGR from 2023 to 2032, driven by the surging prevalence of chronic ailments worldwide.

Hospitals end use segment was valued as over USD 6.5 billion in 2022, fueled by increasing world government focus on improving hospital infrastructure, the market is set to derive notable growth from the segment.

Europe stem cell therapy industry valuation is expected to witness over USD 8 billion by 2032, on account of the increasing occurrence of neurodegenerative diseases in the region creating a strong demand for stem cell therapies.

Some of the prominent market players include Capricor Therapeutics, Cellectis, FUJIFILM Cellular Dynamics, Inc., DiscGenics, Mesoblast Ltd., ThermoGenesis Holdings, Inc., CHIESI Farmaceutici S.p.A., and GSK plc., among others.